Sucralfate Market 2019 | Revenue Opportunies by Top Players SRL Pharma, Nitika Chemicals., Teva Pharmaceutical Industries Ltd., Lisapharma S.p.A, Aptalis Pharma US, Inc., Uniprix Group, Rx Outreach, Abcam Plc, and Quimica Alkano

Increasing research and development activities for discovering new medicine using sucralfate is expected to propel growth of the sucralfate market. For instance, according to the American Broncho Esophagological Association report in April 2018, use of sucralfate along with honey aids in treatment of esophageal injury in infants and children. Esophageal injury in infants and children is associated with consumption of Button Batteries (BB), small disc-shaped batteries commonly found in toys. Use of sucralfate with honey can help in mitigation of the button batteries and allows symptomatic relief from esophageal injury.

Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/2325

Drug shortages are projected to hinder growth of the sucralfate market. For instance, according to Drug Shortages Canada, report of September 2018, APO-SUCRALFATE - TAB 1G (APOTEX INC) that contained sucralfate was not available due to disruption in the manufacturing of the drug. The drug is used to treat peptic ulcer and gastro esophageal reflux disease (GERD).

North America is expected to hold dominant position in the sucralfate market, owing to increasing number of clinical studies. For instance, University of Texas is conducting a clinical phase II study on sucralfate to improve oral intake in children with infectious oral ulcers. The study is expected to be completed by June 2019.

By 2026, Asia Pacific is expected to witness significant growth in the global sucralfate market due to increasing prevalence of H. pylori associated peptic ulcer disease, gastric cancer, and gastric mucosa-associated lymphoid tissue (MALT) lymphoma.

Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2325

Key players operating in the global sucralfate market include, SRL Pharma, Nitika Chemicals., Teva Pharmaceutical Industries Ltd., Lisapharma S.p.A, Aptalis Pharma US, Inc., Uniprix Group, Rx Outreach, Abcam Plc, and Quimica Alkano.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.